Tofacitinib Exposure Does Not Increase Postoperative Complications Among Patients With Ulcerative Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study. [PDF]
Gomaa I +7 more
europepmc +1 more source
[Elephantine Psoriasis. A case report]. [PDF]
Marín-Hernández E +2 more
europepmc +1 more source
[Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Association with Disease Activity and its Impact on Quality of Life]. [PDF]
Briz CM +4 more
europepmc +1 more source
IBD-PODCAST Portugal: Proportion of Patients with Suboptimal Disease Control and Its Impact on Quality of Life in Inflammatory Bowel Disease. [PDF]
Tavares de Sousa H +14 more
europepmc +1 more source
Is a rare <i>CXCL8</i> gene variant a new possible cause or course factor of inflammatory bowel disease? [PDF]
Gabryel M +8 more
europepmc +1 more source
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study. [PDF]
Guijarro LG +23 more
europepmc +1 more source
Respuesta inmunitaria humoral en pacientes con Colitis Ulcerosa
Olga Marina Hano García +3 more
doaj
SummaryEine junge Colitis-ulcerosa-Patientin konnte durch naturheilkundliche Behandlung geheilt werden. Therapiebestandteile waren u. a. Ernährungs- und orthomolekulare Therapie sowie Schwarztee-einläufe.
Volker Schmiedel
exaly +3 more sources
Zusammenfassung. Die Colitis ulcerosa ist eine chronische immunologische Darmerkrankung mit einer Entzündung der Mukosa und teilweise der Submukosa. Sie verläuft schubweise und betrifft im Gegensatz zum Morbus Crohn ausschliesslich das Kolon. Die vielzitierte Ausnahme der kurzstreckigen Beteiligung des terminalen Ileums (sogenannte backwash ileitis ...
Roose, Laura Maria +2 more
core +4 more sources
Ulcerative colitis (UC) and disease Crohn's inflammatory bowel disease are few considered rare and whose epidemiological patterns Clinical REpIER were studied by several years. Asturias, in these studies, has a high inflammatory bowel diseases frequency measured in terms of chronic Rate of Mobility Standardized (provincial National Atlas Rare Diseases.
Vega, Paula +2 more
openaire +2 more sources

